NFE2L3 and neoplasm: Nfe2l3−/− tumors were significantly enriched in the mid section of the colon (87%) compared to the other genotypes where tumors were more evenly distributed between the distal (45%) and mid sections (55%), suggesting location-based differences in tumor signaling.